Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_A8,13 | Lung | Primary cancer | 2,935 | Tumor/Malignant | 38.0% | 0.52 | 0.73 |
| NSCLC_38242124__IMC__88_A8,14 | Lung | Primary cancer | 2,259 | Tumor/Malignant | 51.0% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__88_A8,15 | Lung | Primary cancer | 2,669 | Tumor/Malignant | 52.2% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__88_A8,2 | Lung | Primary cancer | 3,251 | Tumor/Malignant | 39.0% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__88_A8,3 | Lung | Primary cancer | 2,827 | Tumor/Malignant | 64.1% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__88_A8,4 | Lung | Primary cancer | 2,008 | Stromal | 34.3% | 0.63 | 0.72 |
| NSCLC_38242124__IMC__88_A8,5 | Lung | Primary cancer | 2,592 | Tumor/Malignant | 40.7% | 0.92 | 0.27 |
| NSCLC_38242124__IMC__88_A8,6 | Lung | Primary cancer | 952 | Tumor/Malignant | 68.4% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__88_A8,7 | Lung | Primary cancer | 3,087 | Tumor/Malignant | 78.1% | 0.97 | 0.09 |
| NSCLC_38242124__IMC__88_A8,8 | Lung | Primary cancer | 3,789 | Tumor/Malignant | 87.0% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__88_A8,9 | Lung | Primary cancer | 2,808 | Tumor/Malignant | 76.3% | 0.95 | 0.14 |
| NSCLC_38242124__IMC__88_B1,1 | Lung | Primary cancer | 4,170 | Tumor/Malignant | 49.8% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__88_B1,10 | Lung | Primary cancer | 3,178 | Tumor/Malignant | 63.2% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__88_B1,11 | Lung | Primary cancer | 8,194 | Immune | 48.0% | 0.79 | 0.44 |
| NSCLC_38242124__IMC__88_B1,12 | Lung | Primary cancer | 2,767 | Tumor/Malignant | 64.5% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__88_B1,14 | Lung | Primary cancer | 3,280 | Tumor/Malignant | 38.0% | 0.76 | 0.53 |
| NSCLC_38242124__IMC__88_B1,15 | Lung | Primary cancer | 2,914 | Stromal | 40.2% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__88_B1,16 | Lung | Primary cancer | 2,650 | Tumor/Malignant | 78.5% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__88_B1,2 | Lung | Primary cancer | 3,987 | Tumor/Malignant | 66.4% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__88_B1,3 | Lung | Primary cancer | 4,072 | Immune | 33.0% | 0.45 | 0.86 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_A8,13 | Lung | Primary cancer | 2,935 | Tumor/Malignant | 34.4% | 0.64 | 0.68 |
| NSCLC_38242124__IMC__88_A8,14 | Lung | Primary cancer | 2,259 | Tumor/Malignant | 46.4% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__88_A8,15 | Lung | Primary cancer | 2,669 | Tumor/Malignant | 50.4% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__88_A8,2 | Lung | Primary cancer | 3,251 | Tumor/Malignant | 37.1% | 0.95 | 0.17 |
| NSCLC_38242124__IMC__88_A8,3 | Lung | Primary cancer | 2,827 | Tumor/Malignant | 64.3% | 0.98 | 0.10 |
| NSCLC_38242124__IMC__88_A8,4 | Lung | Primary cancer | 2,008 | Tumor/Malignant | 29.7% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__88_A8,5 | Lung | Primary cancer | 2,592 | Tumor/Malignant | 26.7% | 0.70 | 0.67 |
| NSCLC_38242124__IMC__88_A8,6 | Lung | Primary cancer | 952 | Tumor/Malignant | 65.1% | 0.98 | 0.06 |
| NSCLC_38242124__IMC__88_A8,7 | Lung | Primary cancer | 3,087 | Tumor/Malignant | 67.5% | 1.00 | 0.03 |
| NSCLC_38242124__IMC__88_A8,8 | Lung | Primary cancer | 3,789 | Tumor/Malignant | 72.8% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__88_A8,9 | Lung | Primary cancer | 2,808 | Tumor/Malignant | 55.8% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__88_B1,1 | Lung | Primary cancer | 4,170 | Tumor/Malignant | 49.1% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__88_B1,10 | Lung | Primary cancer | 3,178 | Tumor/Malignant | 60.1% | 0.98 | 0.11 |
| NSCLC_38242124__IMC__88_B1,11 | Lung | Primary cancer | 8,194 | Myeloid | 48.2% | 0.79 | 0.44 |
| NSCLC_38242124__IMC__88_B1,12 | Lung | Primary cancer | 2,767 | Tumor/Malignant | 64.5% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__88_B1,14 | Lung | Primary cancer | 3,280 | Tumor/Malignant | 37.5% | 0.76 | 0.53 |
| NSCLC_38242124__IMC__88_B1,15 | Lung | Primary cancer | 2,914 | Stromal | 38.1% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__88_B1,16 | Lung | Primary cancer | 2,650 | Tumor/Malignant | 79.3% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__88_B1,2 | Lung | Primary cancer | 3,987 | Tumor/Malignant | 45.6% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__88_B1,3 | Lung | Primary cancer | 4,072 | Lymphoid | 25.0% | 0.33 | 1.02 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_A8,13 | Lung | Primary cancer | 2,935 | Tumor/Malignant cell | 43.1% | 0.91 | 0.35 |
| NSCLC_38242124__IMC__88_A8,14 | Lung | Primary cancer | 2,259 | Tumor/Malignant cell | 50.3% | 0.96 | 0.17 |
| NSCLC_38242124__IMC__88_A8,15 | Lung | Primary cancer | 2,669 | Tumor/Malignant cell | 51.7% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__88_A8,2 | Lung | Primary cancer | 3,251 | Tumor/Malignant cell | 38.1% | 0.95 | 0.19 |
| NSCLC_38242124__IMC__88_A8,3 | Lung | Primary cancer | 2,827 | Tumor/Malignant cell | 67.5% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__88_A8,4 | Lung | Primary cancer | 2,008 | Fibroblast | 32.2% | 0.54 | 0.87 |
| NSCLC_38242124__IMC__88_A8,5 | Lung | Primary cancer | 2,592 | Tumor/Malignant cell | 40.2% | 0.93 | 0.26 |
| NSCLC_38242124__IMC__88_A8,6 | Lung | Primary cancer | 952 | Tumor/Malignant cell | 72.0% | 0.96 | 0.09 |
| NSCLC_38242124__IMC__88_A8,7 | Lung | Primary cancer | 3,087 | Tumor/Malignant cell | 80.4% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__88_A8,8 | Lung | Primary cancer | 3,789 | Tumor/Malignant cell | 88.2% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__88_A8,9 | Lung | Primary cancer | 2,808 | Tumor/Malignant cell | 76.6% | 0.95 | 0.14 |
| NSCLC_38242124__IMC__88_B1,1 | Lung | Primary cancer | 4,170 | Tumor/Malignant cell | 49.6% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__88_B1,10 | Lung | Primary cancer | 3,178 | Tumor/Malignant cell | 63.4% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__88_B1,11 | Lung | Primary cancer | 8,194 | Granulocyte | 73.4% | 0.91 | 0.24 |
| NSCLC_38242124__IMC__88_B1,12 | Lung | Primary cancer | 2,767 | Tumor/Malignant cell | 74.1% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__88_B1,14 | Lung | Primary cancer | 3,280 | Tumor/Malignant cell | 57.8% | 0.93 | 0.21 |
| NSCLC_38242124__IMC__88_B1,15 | Lung | Primary cancer | 2,914 | Fibroblast | 41.9% | 0.95 | 0.14 |
| NSCLC_38242124__IMC__88_B1,16 | Lung | Primary cancer | 2,650 | Tumor/Malignant cell | 79.3% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__88_B1,2 | Lung | Primary cancer | 3,987 | Tumor/Malignant cell | 65.4% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__88_B1,3 | Lung | Primary cancer | 4,072 | Fibroblast | 25.5% | 0.68 | 0.72 |